ANVISA-2020-0005-V305

Type II variation for application ANVISA-2020-0005. Type II variation: Container Closure Change for Immunovant-α — routine update

Variation Number
ANVISA-2020-0005-V305
Type
Type II
Application
ANVISA-2020-0005
Change
CHG-2024-0005
Status
Overdue
Fee
€49,707
Submitted
2022-11-23
Approved
—
Description

Type II variation: Container Closure Change for Immunovant-α — routine update